Robert Aspbury

Rob Aspbury, PhD, is the President of Certara’s Simcyp division. Prior to this appointment, he served as Simcyp’s Chief Operating Officer. Simcyp provides Population-based Pharmacokinetic Modeling which is used during…

US Managed Markets

  Launch Planning & 360 Reimbursement Pricing Research & Contracting Strategy Early Value & Due Diligence Value Strategy & Evidence Platforms Value Framework & ‘Icer’ – Assessments Health Systems &…

Rajesh Krishna

Dr. Krishna has more than 20 years of drug development experience. His past appointments include leadership roles in product value enhancement and quantitative clinical pharmacology, which he founded (Merck), clinical…

Phoenix NLME Validation Suite

As required by US FDA’s 21 CFR Part 11, International Conference on Harmonization of Technical Requirements (ICH), EudraLex Annex 11, and other regulatory agency guidance documents, computer systems used in…

Phoenix WinNonlin

Certara software support remains unchanged and is available 24/5 by calling (919) 589-2465 or through the support portal Certara.service-now.com/csm Phoenix WinNonlin: The Industry Standard for NCA and PK/PD Modeling…

Phoenix

Certara software support remains unchanged and is available 24/5 by calling (919) 589-2465 or through the support portal Certara.service-now.com/csm Phoenix PK/PD Modeling and Simulation Software   Certara’s Phoenix® platform…